ClinicalTrials.Veeva

Menu

Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy

A

Assiut University

Status

Unknown

Conditions

Breast Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05141279
CESM in breast cancer

Details and patient eligibility

About

The aim of this work to evaluate the accuracy of contrast enhanced spectral mamography in predicting the response to NAC and assessment of residual disease in breast cancer patients

Full description

This a prospective series ,will be performed for 50 patients diagnosed by biopsy as breast cancer who will be scheduled for surgery after completing the full coarse of neoadjuvant chemotherapy

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient confirmed diagnosed by early breast cancer decided to received neoadjuvant treatment
  • locally advanced breast cancer
  • operable metastatic breast cancer

Exclusion criteria

  • patient not candidate for NAC
  • contrast allergy
  • renal impairment
  • pregnancy

Trial design

50 participants in 5 patient groups

1
Description:
Stable
2
Description:
Partial response
3
Description:
Moderate response
4
Description:
Excellent response
5
Description:
Complete response

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems